Last edition
News about "Meenakshi Nevatia"
Pfizer Launches Elranatamab in India for Relapsed or Refractory Multiple Myeloma
Pfizer has launched Elranatamab in India for adults with Relapsed or Refractory Multiple Myeloma (RRMM) who have received at least four prior therapies. The BCMA-directed bispecific antibody is available as a fixed-dose subcutaneous injection, offering a novel treatment option for heavily pretreated multiple myeloma patients.
Meenakshi Nevatia | 03/06/2026 | By News Bureau
Pfizer and Cipla Form Exclusive Marketing Partnership for Select Brands in India
Pfizer and Cipla have joined forces in an exclusive marketing and distribution agreement for select brands in India. The collaboration aims to improve access and availability of these key medicines, ensuring patients across the country benefit from a wider reach and streamlined supply.
Meenakshi Nevatia | 19/12/2025 | By News Bureau | 240
Meenakshi Nevatia joins Pfizer as MD and Additional Director, effective April 3
Nevatia has nearly 30 years of business leadership and consulting experience with top companies
Meenakshi Nevatia | 13/02/2023 | By Sudeep Soparkar | 947
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy